In conclusion, these findings indicate that inadequate NK cell presence in the TME contributes to resistance to anti-PD-L1 therapy in aged mice by impeding the activation of tumor antigen-specific T cells within TDLNs. The gene discussed is CD274; the disease is neoplasm.